glp-1 drugs hypothyroidism glp 1 and Glucagon-like peptide receptor agonist use risk of thyroid cancer: Scandinavian cohort study Receptor Agonists and Thyroid – GLP-1 Medications and Autoimmune Thyroid

Insulin blunts GH release

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumourigenic effects in ovarian cancer

View product Research Product CJC/Ipamorelin Blend This blend combines CJC-1295 (No DAC) and Ipamorelintwo research peptides that act synergistically on the growth hormone (GH) axis

Summary: Researchers unmasked a slight, statistically measurable increase in the risk of developing a rare, potentially permanent blinding condition known as ischemic optic neuropathy (a sudden restriction of blood flow to the optic nerve) among patients initiating GLP-1 therapy compared to standard diabetes regimens

Do KQ, Trabesinger AH, Kirsten-Krger M, Lauer CJ, Dydak U, Hell D et al (2000)

At VYVE Wellness, we work exclusively with certified compounding pharmacies that follow strict purity and sterility standards